These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35234559)

  • 41. Survey of Palliative Sedation at End of Life in Terminally Ill Heart Failure Patients　- A Single-Center Experience of 5-Year Follow-up.
    Hamatani Y; Nakai E; Nakamura E; Miyata M; Kawano Y; Takada Y; Anchi Y; Funabashi S; Hirayama A; Kuroda K; Amano M; Sugano Y; Anzai T; Izumi C
    Circ J; 2019 Jun; 83(7):1607-1611. PubMed ID: 31168045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone?
    Haglund NA; Cox ZL; Lee JT; Song Y; Keebler ME; DiSalvo TG; Maltais S; Lenihan DJ; Wigger MA
    J Card Fail; 2014 Sep; 20(9):630-7. PubMed ID: 24954426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased cost effectiveness with nesiritide vs. milrinone or dobutamine in the treatment of acute decompensated heart failure.
    Scroggins N; Edwards M; Delgado R
    Congest Heart Fail; 2005; 11(6):311-4. PubMed ID: 16330906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Home inotropic therapy in children.
    Berg AM; Snell L; Mahle WT
    J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. It's Time to Talk: Challenges in Providing Integrated Palliative Care in Advanced Congestive Heart Failure. A Narrative Review.
    Chow J; Senderovich H
    Curr Cardiol Rev; 2018; 14(2):128-137. PubMed ID: 29366424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measuring quality of life in advanced heart failure.
    MacIver J; Wentlandt K; Ross HJ
    Curr Opin Support Palliat Care; 2017 Mar; 11(1):12-16. PubMed ID: 27926542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intermittent positive inotrope infusion in the management of end-stage, low-output heart failure.
    Levine BS
    J Cardiovasc Nurs; 2000 Jul; 14(4):76-93. PubMed ID: 10902105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Palliative needs for heart failure or chronic obstructive pulmonary disease: Results of a multicenter observational registry.
    Gavazzi A; De Maria R; Manzoli L; Bocconcelli P; Di Leonardo A; Frigerio M; Gasparini S; Humar F; Perna G; Pozzi R; Svanoni F; Ugolini M; Deales A
    Int J Cardiol; 2015 Apr; 184():552-558. PubMed ID: 25767016
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The palliative care in heart failure trial: rationale and design.
    Mentz RJ; Tulsky JA; Granger BB; Anstrom KJ; Adams PA; Dodson GC; Fiuzat M; Johnson KS; Patel CB; Steinhauser KE; Taylor DH; O'Connor CM; Rogers JG
    Am Heart J; 2014 Nov; 168(5):645-651.e1. PubMed ID: 25440791
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Social Worker-Aided Palliative Care Intervention in High-risk Patients With Heart Failure (SWAP-HF): A Pilot Randomized Clinical Trial.
    O'Donnell AE; Schaefer KG; Stevenson LW; DeVoe K; Walsh K; Mehra MR; Desai AS
    JAMA Cardiol; 2018 Jun; 3(6):516-519. PubMed ID: 29641819
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
    J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
    Dobashi S; Watanabe I; Nakanishi R; Hisatake S; Kiuchi S; Kabuki T; Oka T; Fujii T; Ikeda T
    Heart Vessels; 2020 Jun; 35(6):776-785. PubMed ID: 31865433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.
    Cuffe MS; Califf RM; Adams KF; Bourge RC; Colucci W; Massie B; O'Connor CM; Pina I; Quigg R; Silver M; Robinson LA; Leimberger JD; Gheorghiade M
    Am Heart J; 2000 Jan; 139(1 Pt 1):15-22. PubMed ID: 10618557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure.
    Hatzizacharias A; Makris T; Krespi P; Triposkiadis F; Voyatzi P; Dalianis N; Kyriakidis M
    Am Heart J; 1999 Aug; 138(2 Pt 1):241-6. PubMed ID: 10426834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inotropic therapy for end-stage heart failure patients.
    Toma M; Starling RC
    Curr Treat Options Cardiovasc Med; 2010 Oct; 12(5):409-19. PubMed ID: 20842563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
    Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
    Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.
    Mody BP; Khan MH; Zaid S; Ahn C; Lloji A; Aronow WS; Gupta CA; Levine A; Gass AL; Cooper HA; Lanier GM
    Am J Ther; 2020 Oct; 28(6):e621-e630. PubMed ID: 33021537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
    Brozena SC; Twomey C; Goldberg LR; Desai SS; Drachman B; Kao A; Popjes E; Zimmer R; Jessup M
    J Heart Lung Transplant; 2004 Sep; 23(9):1082-6. PubMed ID: 15454175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experience of morphine therapy for refractory dyspnea as palliative care in advanced heart failure patients.
    Kawaguchi J; Hamatani Y; Hirayama A; Nishimura K; Nakai E; Nakamura E; Miyata M; Kawano Y; Takada Y; Anchi Y; Funabashi S; Kuroda K; Azechi M; Takahama H; Anzai T; Yasuda S; Kitaoka H; Izumi C
    J Cardiol; 2020 Jun; 75(6):682-688. PubMed ID: 32061472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.